Latest / Cell & Gene: The Podcast

Rewriting the Playbook for Stargardt Disease with Atsena Therapeutics' Shannon Boye, Ph.D.
We love to hear from our listeners. Send us a message.
Episode 134 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Shannon Boye, PhD, Founder and CSO of Atsena Therapeutics. Dr. Boye shares how the company is approaching Stargardt disease with a differentiated gene therapy strategy built around delivery, dual-vector design, and a disciplined go/no-go framework. Their conversation also explores what Atsena’s broader clinical experience is teaching the team as it advances new programs and works toward the clinic.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.